|
Orthologous residues
|
|
FLT3 (human): Y969‑p, FLT3 (mouse): Q971‑p, FLT3 iso3 (mouse): Y972‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
immunoprecipitation, phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
BaF3 ('B lymphocyte, precursor'), COS (fibroblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
monkey, mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
FL
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Effect of modification (process):
cell cycle regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
Grb2 (human)
|
|
Induces
|
molecular association, regulation
|
|
co-immunoprecipitation
|
|
|
Comments:
regulates cell proliferation
|